Clinical Trials Browser

Phase 2 × Neoplasms, Second Primary × 1 year × Clear all

NCT04634071 2026-02-02

TTOP

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

NCT05217069 2025-04-16

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Phase 2 Completed

Neoplasms, Second Primary